NASDAQ:REVB

Revelation Biosciences Stock Forecast

etoro logo Buy REVB
*Your capital is at risk
$0.98
+0.0069 (+0.713%)
At Close: Jul 09, 2026
AI Analysis AI Analysis of REVB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add REVB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Revelation Biosciences, Inc. stock downgraded to Sell Candidate
(Updated on Jul 09, 2026)

Sell candidate since Jul 09, 2026

The Revelation Biosciences, Inc. stock price gained 0.713% on the last trading day (Thursday, 9th Jul 2026), rising from $0.97 to $0.98. During the last trading day the stock fluctuated 5.23% from a day low at $0.95 to a day high of $1.00. The price has been going up and down for this period, and there has been a -5.34% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 16 thousand more shares were traded than the day before. In total, 35 thousand shares were bought and sold for approximately $34.16 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.30% during the next 3 months and, with a 90% probability hold a price between $0.718 and $0.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

REVB Signals & Forecast

There are mixed signals in the stock today. The Revelation Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.01 and $1.03. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Friday, May 08, 2026, and so far it has risen 1.56%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Revelation Biosciences, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Revelation Biosciences, Inc. stock

Revelation Biosciences, Inc. finds support from accumulated volume at $0.97 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0497 between high and low, or 5.23%. For the last week, the stock has had daily average volatility of 5.86%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (REVB) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Revelation Biosciences, Inc. to open at $0.98, and during the day (based on 14 day Average True Range), to move between $0.95 and $1.00, which gives a possible trading interval of +/-$0.0593 (+/-6.27%) up or down from last closing price. If Revelation Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 6.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.97 (0.71%) than the resistance at $1.04 (6.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Revelation Biosciences, Inc. stock A Buy?

Revelation Biosciences, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.398 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 10, 2026 - $0.98 ( 0.0034%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

REVB Performance

Trading levels for REVB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.02 5.10%
R2 1.01 3.15%
R1 0.99 1.95%
Price 0.98
S1 0.96 -1.94%
S2 0.94 -3.15%
S3 0.93 -5.09%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.16 18.97%
R2 1.15 17.44%
R1 1.04 6.67%
Price 0.98
S1 0.97 -0.708%
S2 0.96 -1.44%
S3 0.96 -1.54%

FAQ

What is the symbol for Revelation Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Revelation Biosciences, Inc. is REVB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Revelation Biosciences, Inc. Stock?
Revelation Biosciences, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Revelation Biosciences, Inc. Stock?
Revelation Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Revelation Biosciences, Inc. Stock.

What's the current price of Revelation Biosciences, Inc. Stock?
As of the end of day on the Jul 09, 2026, the price of an Revelation Biosciences, Inc. (REVB) share was $0.98.

What is the 52-week high and low for Revelation Biosciences, Inc. Stock?
The 52-week high for Revelation Biosciences, Inc. Stock is $12.84 and the 52-week low is $0.88.

What is the market capitalization of Revelation Biosciences, Inc. Stock?
As of the Jul 09, 2026, the market capitalization of Revelation Biosciences, Inc. is 3.811M.

When is the next earnings date for Revelation Biosciences, Inc.?
The upcoming earnings date for Revelation Biosciences, Inc. is Aug 07, 2026.
Click to get the best stock tips daily for free!
ABOUT REVELATION BIOSCIENCES, INC.
Revelation Biosciences
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is a...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
18.74% Jun 29
NMRK
$15.02
2.53% Jun 24
X
XMAX
$8.34
3.48% Jun 24
JLL
$299.78
8.09% Jun 24
TTEK
$28.04
9.81% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE